| Name | Secukinumab |
|---|
| Description | Secukinumab is a fully human immunoglobulin G1-kappa monoclonal antibody that directly inhibits interleukin (IL)-17A, has been shown to have robust efficacy in the treatment of moderate-to-severe psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing |
|---|
| Molecular Formula | C237H360IN8O42P7-14 |
|---|---|
| Molecular Weight | 4337 |
| Exact Mass | 4336.35553 |